/
CCM
$4.73+$0.04 (+0.85%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$20.4M
4M shares
52-week range
$3.18 – $10.77
20% from low
Exchange
NYSE
ADRC
Borrow rate
4.06%
Moderate
Price (6 mo)
Loading chart…
Change$-24.87
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $190.9M | $198.4M | $223.0M | $485.6M | $472.1M | $537.4M | $384.0M | $460.5M |
| Cost of revenue | $171.1M | $214.2M | $209.9M | $542.5M | $624.5M | $614.0M | $463.1M | $434.7M |
| Gross profit | $19.8M | −$15.8M | $13.1M | −$56.9M | −$152.4M | −$76.6M | −$79.2M | $25.8M |
| Gross margin | 10.4% | -8.0% | 5.9% | -11.7% | -32.3% | -14.3% | -20.6% | 5.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$299.2M | −$437.3M | −$316.0M | −$458.3M | −$525.0M | −$463.0M | −$532.2M | −$239.3M |
| EBITDA | −$248.8M | −$304.9M | −$236.7M | −$363.9M | −$401.9M | −$344.2M | −$345.6M | −$71.8M |
| Net income | −$234.9M | −$307.0M | −$310.0M | −$271.4M | −$489.7M | −$297.7M | −$308.2M | −$92.8M |
| Net margin | -123.0% | -154.8% | -139.0% | -55.9% | -103.7% | -55.4% | -80.3% | -20.2% |
| EPS (diluted) | -2484.90 | -3818.10 | -4600.50 | -5635.50 | -3362.70 | -2044.20 | -2116.80 | -621.00 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $440M | $-18.25 | $-18.25–$-18.25 | 1 |
| 2027 | $245M | $4.18 | $4.18–$4.18 | 1 |
| 2028 | $184M | $-7.03 | $-7.03–$-7.03 | 1 |
| 2029 | $242M | $-15.72 | $-15.72–$-15.72 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$998519.04
Price
$4.73
Implied upside
+21110239%
Peer comparison
Concord Medical Services Holding Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
www.concordmedical.com- Employees
- 610
- IPO / List date
- Dec 11, 2009
Held by traders on TradeandTell
No one on the platform currently holds CCM.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CCM as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-07-30 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded CCM yet.
